Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223453

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223453

Europe Fecal Occult Blood Tests Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 304 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

Europe fecal occult blood testing market is projected to register a substantial CAGR of 5.1 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Europe Fecal Occult Blood Tests Market, By Test Type (Lateral Flow Immuno-Fob Test Kits, Immuno-FOB Agglutination Test Kits, Immuno-FOB ELISA Test Kits, Guaiac FOB Stool Test, Flushable Reagent Pad or Tissue, and Others), By Application (Colorectal Cancer Screening, Concern for Gastrointestinal Bleeding, Polyps, Diverticulosis, Ulcers, Haemorrhoids, Colitis, Anemia, and Others), By End User (Diagnostic Laboratories, Hospitals, Speciality Clinics, and Others), By Distribution Channel (Direct Sales, Retail Sales, E-Commerce, and Others), Country

(Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Turkey, Belgium and the rest of Europe), Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Europe fecal occult blood testing market are:

Rising cases of colorectal cancer globally

Development of direct-to-consumer laboratory testing

Increasing inclination towards point-of-care diagnostics

Easy availability of fecal occult immunological test devices in online stores

Market Players

Some of the key market players for the Europe fecal occult blood testing market are listed below:

Quidel Corporation

Siemens Healthcare GmbH

Biohit Oyj

Accubiotech Co. Ltd.

Accuquik Test Kits

Aidian

Alfa Scientific Designs, Inc.

Apacor Limited

Others

Show more

TABLE OF CONTENTS

1 INTRODUCTION 75

  • 1.1 OBJECTIVES OF THE STUDY 75
  • 1.2 MARKET DEFINITION 75
  • 1.3 OVERVIEW OF THE EUROPE FECAL OCCULT BLOOD TESTS MARKET 75
  • 1.4 CURRENCY AND PRICING 77
  • 1.5 LIMITATIONS 77
  • 1.6 MARKETS COVERED 77

2 MARKET SEGMENTATION 81

  • 2.1 MARKETS COVERED 81
  • 2.2 GEOGRAPHICAL SCOPE 82
  • 2.3 YEARS CONSIDERED FOR THE STUDY 83
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 84
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 87
  • 2.6 MULTIVARIATE MODELLING 88
  • 2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 88
  • 2.8 MARKET APPLICATION COVERAGE GRID 89
  • 2.9 DBMR MARKET POSITION GRID 90
  • 2.10 VENDOR SHARE ANALYSIS 91
  • 2.11 SECONDARY SOURCES 92
  • 2.12 ASSUMPTIONS 92

3 EXECUTIVE SUMMARY 93

4 PREMIUM INSIGHTS 95

  • 4.1 PESTEL ANALYSIS 96
  • 4.2 PORTER'S 5 FORCES 97

5 INDUSTRY INSIGHTS 98

6 REGULATORY FRAMEWORK 100

  • 6.1 REGULATORY SCENARIO BY U.S. FDA 100
  • 6.2 REGULATORY SCENARIO IN U.S. 100
  • 6.3 REGULATORY SCENARIO IN EUROPE 101
  • 6.4 REGULATORY SCENARIO IN CANADA 101
  • 6.5 REGULATORY SCENARIO IN AUSTRALIA 101

7 MARKET OVERVIEW 102

  • 7.1 DRIVERS 104
    • 7.1.1 RISING CASES OF COLORECTAL CANCER EUROPELY 104
    • 7.1.2 DEVELOPMENT OF DIRECT-TO-CONSUMER LABORATORY TESTING 104
    • 7.1.3 EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES 105
    • 7.1.4 INCREASING INCLINATION TOWARDS POINT-OF-CARE DIAGNOSTICS 105
  • 7.2 RESTRAINTS 105
    • 7.2.1 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES 105
    • 7.2.2 LOW AWARENESS ABOUT FECAL OCCULT BLOOD TESTS IN UNDEVELOPED COUNTRIES 106
  • 7.3 OPPORTUNITIES 106
    • 7.3.1 INCREASE IN SCREENING PROCEDURES 106
    • 7.3.2 RISING TECHNICAL ADVANCEMENTS 107
    • 7.3.3 STRATEGIC INITIATIVES 107
  • 7.4 CHALLENGES 108
    • 7.4.1 LACK OF SKILLED PROFESSIONALS 108
    • 7.4.2 LOW EFFICIENCY 108

8 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE 109

  • 8.1 OVERVIEW 110
  • 8.2 LATERAL FLOW IMMUNO-FOB TEST KITS 113
  • 8.3 IMMUNO-FOB AGGLUTINATION TEST KITS 113
  • 8.4 IMMUNO-FOB ELISA TEST KITS 114
  • 8.5 GUAIAC FOB STOOL TEST 115
    • 8.5.1 KITS 116
      • 8.5.1.1 GUAIAC SLIDES 116
        • 8.5.1.1.1 25 PACKAGE 116
        • 8.5.1.1.2 20 PACKAGE 116
        • 8.5.1.1.3 OTHERS 116
      • 8.5.1.2 ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER 117
        • 8.5.1.2.1 SENSITIVITY IS 50NG/ML 117
        • 8.5.1.2.1.1 25 PACKAGE 117
        • 8.5.1.2.1.2 20 PACKAGE 117
        • 8.5.1.2.1.3 OTHERS 118
        • 8.5.1.2.2 SENSITIVITY IS 75NG/ML 118
        • 8.5.1.2.2.1 25 PACKAGE 118
        • 8.5.1.2.2.2 20 PACKAGE 118
        • 8.5.1.2.2.3 OTHERS 118
        • 8.5.1.2.3 OTHERS 118
      • 8.5.1.3 OTHERS 119
    • 8.5.2 REAGENTS 119
      • 8.5.2.1 HYDROGEN PEROXIDE 119
      • 8.5.2.2 OTHERS 119
  • 8.6 FLUSHABLE REAGENT PAD OR TISSUE 119
  • 8.7 OTHERS 120

9 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION 121

  • 9.1 OVERVIEW 122
  • 9.2 COLORECTAL CANCER SCREENING 125
    • 9.2.1 LATERAL FLOW IMMUNO-FOB TEST KITS 126
    • 9.2.2 IMMUNO-FOB AGGLUTINATION TEST KITS 126
    • 9.2.3 IMMUNO-FOB ELISA TEST KITS 126
    • 9.2.4 GUAIAC FOB STOOL TEST 126
    • 9.2.5 FLUSHABLE REAGENT PAD OR TISSUE 126
    • 9.2.6 OTHERS 126
  • 9.3 CONCERN FOR GASTROINTESTINAL BLEEDING 126
    • 9.3.1 LATERAL FLOW IMMUNO-FOB TEST KITS 127
    • 9.3.2 IMMUNO-FOB AGGLUTINATION TEST KITS 127
    • 9.3.3 IMMUNO-FOB ELISA TEST KITS 127
    • 9.3.4 GUAIAC FOB STOOL TEST 128
    • 9.3.5 FLUSHABLE REAGENT PAD OR TISSUE 128
    • 9.3.6 OTHERS 128
  • 9.4 POLYPS 128
    • 9.4.1 LATERAL FLOW IMMUNO-FOB TEST KITS 129
    • 9.4.2 IMMUNO-FOB AGGLUTINATION TEST KITS 129
    • 9.4.3 IMMUNO-FOB ELISA TEST KITS 129
    • 9.4.4 GUAIAC FOB STOOL TEST 129
    • 9.4.5 FLUSHABLE REAGENT PAD OR TISSUE 129
    • 9.4.6 OTHERS 129
  • 9.5 DIVERTICULOSIS 130
    • 9.5.1 LATERAL FLOW IMMUNO-FOB TEST KITS 131
    • 9.5.2 IMMUNO-FOB AGGLUTINATION TEST KITS 131
    • 9.5.3 IMMUNO-FOB ELISA TEST KITS 131
    • 9.5.4 GUAIAC FOB STOOL TEST 131
    • 9.5.5 FLUSHABLE REAGENT PAD OR TISSUE 131
    • 9.5.6 OTHERS 131
  • 9.6 ULCERS 131
    • 9.6.1 LATERAL FLOW IMMUNO-FOB TEST KITS 132
    • 9.6.2 IMMUNO-FOB AGGLUTINATION TEST KITS 132
    • 9.6.3 IMMUNO-FOB ELISA TEST KITS 132
    • 9.6.4 GUAIAC FOB STOOL TEST 133
    • 9.6.5 FLUSHABLE REAGENT PAD OR TISSUE 133
    • 9.6.6 OTHERS 133
  • 9.7 HAEMORRHOIDS 133
    • 9.7.1 LATERAL FLOW IMMUNO-FOB TEST KITS 134
    • 9.7.2 IMMUNO-FOB AGGLUTINATION TEST KITS 134
    • 9.7.3 IMMUNO-FOB ELISA TEST KITS 134
    • 9.7.4 GUAIAC FOB STOOL TEST 134
    • 9.7.5 FLUSHABLE REAGENT PAD OR TISSUE 134
    • 9.7.6 OTHERS 134
  • 9.8 COLITIS 135
    • 9.8.1 LATERAL FLOW IMMUNO-FOB TEST KITS 136
    • 9.8.2 IMMUNO-FOB AGGLUTINATION TEST KITS 136
    • 9.8.3 IMMUNO-FOB ELISA TEST KITS 136
    • 9.8.4 GUAIAC FOB STOOL TEST 136
    • 9.8.5 FLUSHABLE REAGENT PAD OR TISSUE 136
    • 9.8.6 OTHERS 136
  • 9.9 ANEMIA 136
    • 9.9.1 LATERAL FLOW IMMUNO-FOB TEST KITS 137
    • 9.9.2 IMMUNO-FOB AGGLUTINATION TEST KITS 137
    • 9.9.3 IMMUNO-FOB ELISA TEST KITS 137
    • 9.9.4 GUAIAC FOB STOOL TEST 138
    • 9.9.5 FLUSHABLE REAGENT PAD OR TISSUE 138
    • 9.9.6 OTHERS 138
  • 9.10 OTHERS 138

10 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY END USER 139

  • 10.1 OVERVIEW 140
  • 10.2 DIAGNOSTIC LABORATORIES 143
  • 10.3 HOSPITALS 143
  • 10.4 SPECIALITY CLINICS 144
  • 10.5 OTHERS 145

11 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL 146

  • 11.1 OVERVIEW 147
  • 11.2 DIRECT TENDER 150
  • 11.3 RETAIL SALE 150
  • 11.4 E-COMMERCE 151
  • 11.5 OTHERS 152

12 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY REGION 153

  • 12.1 EUROPE 154
    • 12.1.1 GERMANY 169
    • 12.1.2 FRANCE 179
    • 12.1.3 U.K. 189
    • 12.1.4 ITALY 199
    • 12.1.5 SPAIN 209
    • 12.1.6 RUSSIA 219
    • 12.1.7 SWITZERLAND 229
    • 12.1.8 NETHERLANDS 239
    • 12.1.9 TURKEY 249
    • 12.1.10 BELGIUM 259
    • 12.1.11 REST OF EUROPE 269

13 EUROPE FECAL OCCULT BLOOD TESTS MARKET: COMPANY LANDSCAPE 270

  • 13.1 COMPANY SHARE ANALYSIS: EUROPE 270

14 SWOT ANALYSIS 271

15 COMPANY PROFILE 272

  • 15.1 QUIDEL CORPORATION 272
    • 15.1.1 COMPANY SNAPSHOT 272
    • 15.1.2 REVENUE ANALYSIS 272
    • 15.1.3 COMPANY SHARE ANALYSIS 273
    • 15.1.4 PRODUCT PORTFOLIO 273
    • 15.1.5 RECENT DEVELOPMENT 273
  • 15.2 WONDFO. 274
    • 15.2.1 COMPANY SNAPSHOT 274
    • 15.2.2 COMPANY SHARE ANALYSIS 274
    • 15.2.3 PRODUCT PORTFOLIO 275
    • 15.2.4 RECENT DEVELOPMENT 275
  • 15.3 SIEMENS HEALTHCARE GMBH 276
    • 15.3.1 COMPANY SNAPSHOT 276
    • 15.3.2 REVENUE ANALYSIS 276
    • 15.3.3 COMPANY SHARE ANALYSIS 277
    • 15.3.4 RODUCT PORTFOLIO 277
    • 15.3.5 RECENT DEVELOPMENT 277
  • 15.4 EIKEN CHEMICAL CO., LTD. 278
    • 15.4.1 COMPANY SNAPSHOT 278
    • 15.4.2 REVENUE ANALYSIS 278
    • 15.4.3 COMPANY SHARE ANALYSIS 279
    • 15.4.4 PRODUCT PORTFOLIO 279
    • 15.4.5 RECENT DEVELOPMENT 279
  • 15.5 BIOHIT OYJ 280
    • 15.5.1 COMPANY SNAPSHOT 280
    • 15.5.2 REVENUE ANALYSIS 280
    • 15.5.3 COMPANY SHARE ANALYSIS 281
    • 15.5.4 PRODUCT PORTFOLIO 281
    • 15.5.5 RECENT DEVELOPMENT 281
  • 15.6 ACCUBIOTECH CO LTD 282
    • 15.6.1 COMPANY SNAPSHOT 282
    • 15.6.2 PRODUCT PORTFOLIO 282
    • 15.6.3 RECENT DEVELOPMENT 282
  • 15.7 ACCUQUIK TEST KITS 283
    • 15.7.1 COMPANY SNAPSHOT 283
    • 15.7.2 PRODUCT PORTFOLIO 283
    • 15.7.3 RECENT DEVELOPMENT 283
  • 15.8 AIDIAN 284
    • 15.8.1 COMPANY PROFILE 284
    • 15.8.2 PRODUCT PORTFOLIO 284
    • 15.8.3 RECENT DEVELOPMENT 284
  • 15.9 ALFA SCIENTIFIC DESIGNS, INC. 285
    • 15.9.1 COMPANY SNAPSHOT 285
    • 15.9.2 PRODUCT PORTFOLIO 285
    • 15.9.3 RECENT DEVELOPMENT 285
  • 15.10 APACOR LIMITED 286
    • 15.10.1 COMPANY SNAPSHOT 286
    • 15.10.2 PRODUCT PORTFOLIO 286
    • 15.10.3 RECENT DEVELOPMENT 286
  • 15.11 BIOPANDA REAGENTS LTD 287
    • 15.11.1 COMPANY SNAPSHOT 287
    • 15.11.2 PRODUCT PORTFOLIO 287
    • 15.11.3 RECENT DEVELOPMENT 287
  • 15.12 BODITECH MED INC. 288
    • 15.12.1 COMPANY SNAPSHOT 288
    • 15.12.2 PRODUCT PORTFOLIO 288
    • 15.12.3 RECENT DEVELOPMENT 288
  • 15.13 CENOGENICS CORPORATION 289
    • 15.13.1 COMPANY SNAPSHOT 289
    • 15.13.2 PRODUCT PORTFOLIO 289
    • 15.13.3 RECENT DEVELOPMENT 289
  • 15.14 CERTEST BIOTEC. 290
    • 15.14.1 COMPANY SNAPSHOT 290
    • 15.14.2 PRODUCT PORTFOLIO 290
    • 15.14.3 RECENT DEVELOPMENT 290
  • 15.15 CTK BIOTECH, INC. 291
    • 15.15.1 COMPANY SNAPSHOT 291
    • 15.15.2 PRODUCT PORTFOLIO 291
    • 15.15.3 RECENT DEVELOPMENT 291
  • 15.16 EDP BIOTECH 292
    • 15.16.1 COMPANY SNAPSHOT 292
    • 15.16.2 PRODUCT PORTFOLIO 292
    • 15.16.3 1.16.3 RECENT DEVELOPMENT 292
  • 15.17 EPITOPE DIAGNOSTICS, INC. 293
    • 15.17.1 COMPANY SNAPSHOT 293
    • 15.17.2 PRODUCT PORTFOLIO 293
    • 15.17.3 RECENT DEVELOPMENT 293
  • 15.18 EUROLYSER DIAGNOSTICA GMBH 294
    • 15.18.1 COMPANY SNAPSHOT 294
    • 15.18.2 PRODUCT PORTFOLIO 294
    • 15.18.3 RECENT DEVELOPMENT 294
  • 15.19 FIRSTEP 295
    • 15.19.1 COMPANY SNAPSHOT 295
    • 15.19.2 PRODUCT PORTFOLIO 295
    • 15.19.3 RECENT DEVELOPMENT 295
  • 15.20 HANGZHOU CLONGENE BIOTECH CO., LTD 296
    • 15.20.1 COMPANY SNAPSHOT 296
    • 15.20.2 PRODUCT PORTFOLIO 296
    • 15.20.3 RECENT DEVELOPMENT 296
Show more
  • 15.21 HUMASIS.COM 297
    • 15.21.1 COMPANY SNAPSHOT 297
    • 15.21.2 PRODUCT PORTFOLIO 297
    • 15.21.3 RECENT DEVELOPMENT 297
  • 15.22 JANT PHARMACAL CORPORATION 298
    • 15.22.1 COMPANY SNAPSHOT 298
    • 15.22.2 PRODUCT PORTFOLIO 298
    • 15.22.3 RECENT DEVELOPMENT 298
  • 15.23 PRIMA LAB SA 299
    • 15.23.1 COMPANY SNAPSHOT 299
    • 15.23.2 PRODUCT PORTFOLIO 299
    • 15.23.3 RECENT DEVELOPMENT 299
  • 15.24 ULTI MED PRODUCTS (DEUTSCHLAND) GMBH 300
    • 15.24.1 COMPANY SNAPSHOT 300
    • 15.24.2 PRODUCT PORTFOLIO 300
    • 15.24.3 RECENT DEVELOPMENT 300

16 QUESTIONNAIRE 301

17 RELATED REPORTS 304

LIST OF TABLES

  • TABLE 1 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 72
  • TABLE 2 EUROPE LATERAL FLOW IMMUNO-FOB TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 73
  • TABLE 3 EUROPE IMMUNO-FOB AGGLUTINATION TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 74
  • TABLE 4 EUROPE IMMUNO-FOB ELISA TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 74
  • TABLE 5 EUROPE GUAIAC FOB STOOL TEST IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 75
  • TABLE 6 EUROPE GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 75
  • TABLE 7 EUROPE KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
  • TABLE 8 EUROPE GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
  • TABLE 9 EUROPE ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
  • TABLE 10 EUROPE SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
  • TABLE 11 EUROPE SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 78
  • TABLE 12 EUROPE REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 79
  • TABLE 13 EUROPE FLUSHABLE REAGENT PAD OR TISSUE IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 80
  • TABLE 14 EUROPE OTHERS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 80
  • TABLE 15 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 84
  • TABLE 16 EUROPE COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
  • TABLE 17 EUROPE COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
  • TABLE 18 EUROPE CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
  • TABLE 19 EUROPE CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 87
  • TABLE 20 EUROPE POYLPS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
  • TABLE 21 EUROPE POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 89
  • TABLE 22 EUROPE DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
  • TABLE 23 EUROPE DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 90
  • TABLE 24 EUROPE ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
  • TABLE 25 EUROPE ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 92
  • TABLE 26 EUROPE HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
  • TABLE 27 EUROPE HEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 94
  • TABLE 28 EUROPE COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
  • TABLE 29 EUROPE COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 95
  • TABLE 30 EUROPE ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
  • TABLE 31 EUROPE ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 97
  • TABLE 32 EUROPE OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
  • TABLE 33 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 102
  • TABLE 34 EUROPE DIAGNOSTIC LABORATORIES IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
  • TABLE 35 EUROPE HOSPITALS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 36 EUROPE SPECIALITY CLINICS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 37 EUROPE OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
  • TABLE 38 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 109
  • TABLE 39 EUROPE DIRECT TENDER IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 40 EUROPE RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 41 EUROPE RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 42 EUROPE OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
  • TABLE 43 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 118
  • TABLE 44 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 45 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 119
  • TABLE 46 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 119
  • TABLE 47 EUROPE GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 48 EUROPE GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 119
  • TABLE 49 EUROPE GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 120
  • TABLE 50 EUROPE KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 51 EUROPE KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 120
  • TABLE 52 EUROPE KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 120
  • TABLE 53 EUROPE GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 54 EUROPE GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 121
  • TABLE 55 EUROPE GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 121
  • TABLE 56 EUROPE ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 57 EUROPE ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 121
  • TABLE 58 EUROPE ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 121
  • TABLE 59 EUROPE SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 60 EUROPE SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 122
  • TABLE 61 EUROPE SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 122
  • TABLE 62 EUROPE SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 63 EUROPE SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 122
  • TABLE 64 EUROPE SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 123
  • TABLE 65 EUROPE REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 66 EUROPE REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 123
  • TABLE 67 EUROPE REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 123
  • TABLE 68 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
  • TABLE 69 EUROPE COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
  • TABLE 70 EUROPE CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
  • TABLE 71 EUROPE POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
  • TABLE 72 EUROPE DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
  • TABLE 73 EUROPE ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
  • TABLE 74 EUROPE HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
  • TABLE 75 EUROPE COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
  • TABLE 76 EUROPE ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
  • TABLE 77 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 127
  • TABLE 78 EUROPE FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 128
  • TABLE 79 GERMANY FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 80 GERMANY FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 129
  • TABLE 81 GERMANY FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 129
  • TABLE 82 GERMANY GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 83 GERMANY GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 130
  • TABLE 84 GERMANY GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 130
  • TABLE 85 GERMANY KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 86 GERMANY KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 130
  • TABLE 87 GERMANY KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 131
  • TABLE 88 GERMANY GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 89 GERMANY GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 131
  • TABLE 90 GERMANY GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 131
  • TABLE 91 GERMANY ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 92 GERMANY ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 132
  • TABLE 93 GERMANY ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 132
  • TABLE 94 GERMANY SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 95 GERMANY SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 132
  • TABLE 96 GERMANY SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 132
  • TABLE 97 GERMANY SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 98 GERMANY SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 133
  • TABLE 99 GERMANY SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 133
  • TABLE 100 GERMANY REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 101 GERMANY REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 133
  • TABLE 102 GERMANY REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 134
  • TABLE 103 GERMANY FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
  • TABLE 104 GERMANY COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
  • TABLE 105 GERMANY CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
  • TABLE 106 GERMANY POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
  • TABLE 107 GERMANY DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
  • TABLE 108 GERMANY ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
  • TABLE 109 GERMANY HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
  • TABLE 110 GERMANY COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
  • TABLE 111 GERMANY ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
  • TABLE 112 GERMANY FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 138
  • TABLE 113 GERMANY FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 138
  • TABLE 114 FRANCE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 115 FRANCE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 139
  • TABLE 116 FRANCE FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 139
  • TABLE 117 FRANCE GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 118 FRANCE GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 140
  • TABLE 119 FRANCE GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 140
  • TABLE 120 FRANCE KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 121 FRANCE KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 140
  • TABLE 122 FRANCE KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 141
  • TABLE 123 FRANCE GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 124 FRANCE GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 141
  • TABLE 125 FRANCE GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 141
  • TABLE 126 FRANCE ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 127 FRANCE ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 142
  • TABLE 128 FRANCE ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 142
  • TABLE 129 FRANCE SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 130 FRANCE SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 142
  • TABLE 131 FRANCE SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 142
  • TABLE 132 FRANCE SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 133 FRANCE SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 143
  • TABLE 134 FRANCE SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 143
  • TABLE 135 FRANCE REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 136 FRANCE REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 143
  • TABLE 137 FRANCE REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 144
  • TABLE 138 FRANCE FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
  • TABLE 139 FRANCE COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
  • TABLE 140 FRANCE CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
  • TABLE 141 FRANCE POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
  • TABLE 142 FRANCE DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 146
  • TABLE 143 FRANCE ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 146
  • TABLE 144 FRANCE HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 147
  • TABLE 145 FRANCE COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 147
  • TABLE 146 FRANCE ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
  • TABLE 147 FRANCE FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 148
  • TABLE 148 FRANCE FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 148
  • TABLE 149 U.K. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 150 U.K. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 149
  • TABLE 151 U.K. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 149
  • TABLE 152 U.K. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 153 U.K. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 150
  • TABLE 154 U.K. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 150
  • TABLE 155 U.K. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 156 U.K. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 150
  • TABLE 157 U.K. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 151
  • TABLE 158 U.K. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 159 U.K. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 151
  • TABLE 160 U.K. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 151
  • TABLE 161 U.K. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 162 U.K. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 152
  • TABLE 163 U.K. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 152
  • TABLE 164 U.K. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 165 U.K. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 152
  • TABLE 166 U.K. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 152
  • TABLE 167 U.K. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 168 U.K. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 153
  • TABLE 169 U.K. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 153
  • TABLE 170 U.K. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 171 U.K. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 153
  • TABLE 172 U.K. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 154
  • TABLE 173 U.K. FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 154
  • TABLE 174 U.K. COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 154
  • TABLE 175 U.K. CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 155
  • TABLE 176 U.K. POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 155
  • TABLE 177 U.K. DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 156
  • TABLE 178 U.K. ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 156
  • TABLE 179 U.K. HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 157
  • TABLE 180 U.K. COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 157
  • TABLE 181 U.K. ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 158
  • TABLE 182 U.K. FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 158
  • TABLE 183 U.K. FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 158
  • TABLE 184 ITALY FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 185 ITALY FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 159
  • TABLE 186 ITALY FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 159
  • TABLE 187 ITALY GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 188 ITALY GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 160
  • TABLE 189 ITALY GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 160
  • TABLE 190 ITALY KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 191 ITALY KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 160
  • TABLE 192 ITALY KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 161
  • TABLE 193 ITALY GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 194 ITALY GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 161
  • TABLE 195 ITALY GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 161
  • TABLE 196 ITALY ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 197 ITALY ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 162
  • TABLE 198 ITALY ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 162
  • TABLE 199 ITALY SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162

LIST OF FIGURES

  • FIGURE 1 EUROPE FECAL OCCULT BLOOD TESTSMARKET: SEGMENTATION 40
  • FIGURE 2 EUROPE FECAL OCCULT BLOOD TESTS MARKET: DATA TRIANGULATION 43
  • FIGURE 3 EUROPE FECAL OCCULT BLOOD TESTS MARKET: DROC ANALYSIS 44
  • FIGURE 4 EUROPE FECAL OCCULT BLOOD TESTS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 45
  • FIGURE 5 EUROPE FECAL OCCULT BLOOD TESTS MARKET: COMPANY RESEARCH ANALYSIS 45
  • FIGURE 6 EUROPE FECAL OCCULT BLOOD TESTS MARKET: INTERVIEW DEMOGRAPHICS 46
  • FIGURE 7 EUROPE FECAL OCCULT BLOOD TESTS MARKET: MARKET APPLICATION COVERAGE GRID 48
  • FIGURE 8 EUROPE FECAL OCCULT BLOOD TESTSMARKET: DBMR MARKET POSITION GRID 49
  • FIGURE 9 EUROPE FECAL OCCULT BLOOD TESTS MARKET: VENDOR SHARE ANALYSIS 50
  • FIGURE 10 EUROPE FECAL OCCULT BLOOD TESTS MARKET: SEGMENTATION 53
  • FIGURE 11 RISING CASES OF COLORECTAL CANCER EUROPELY AND EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES ARE EXPECTED TO DRIVE THE GROWTH OF THE EUROPE FECAL OCCULT BLOOD TESTS MARKET FROM 2023 TO 2030 54
  • FIGURE 12 THE LATERAL FLOW IMMUNO-FOB, TEST KITS SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE FECAL OCCULT BLOOD TESTS MARKET IN 2023 & 2030 54
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE FECAL OCCULT BLOOD TESTS MARKET 62
  • FIGURE 14 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2022 69
  • FIGURE 15 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 70
  • FIGURE 16 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, CAGR (2023-2030) 70
  • FIGURE 17 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, LIFELINE CURVE 71
  • FIGURE 18 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2022 81
  • FIGURE 19 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 82
  • FIGURE 20 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, CAGR (2023-2030) 82
  • FIGURE 21 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, LIFELINE CURVE 83
  • FIGURE 22 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2022 99
  • FIGURE 23 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2023-2030 (USD MILLION) 100
  • FIGURE 24 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY END USER, CAGR (2023-2030) 100
  • FIGURE 25 EUROPE FECAL OCCULT BLOOD TESTS MARKET : BY END USER, LIFELINE CURVE 101
  • FIGURE 26 EUROPE FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2022 106
  • FIGURE 27 EUROPE FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 107
  • FIGURE 28 EUROPE FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 107
  • FIGURE 29 EUROPE FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 108
  • FIGURE 30 EUROPE FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 114
  • FIGURE 31 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 115
  • FIGURE 32 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 115
  • FIGURE 33 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 116
  • FIGURE 34 EUROPE FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE (2023-2030) 116
  • FIGURE 35 EUROPE FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 229
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!